https://www.live-feeds.com/feed/abbott-cuts-2026-sales-growth-view-plans-to-spin-off-nutrition-businessContinuously updated, source-cited coverage. https://www.live-feeds.com/feed/abbott-cuts-2026-sales-growth-view-plans-to-spin-off-nutrition-businesshttps://www.live-feeds.com/feed/abbott-cuts-2026-sales-growth-view-plans-to-spin-off-nutrition-business#u154385Sun, 25 Oct 2026 14:50:29 +0000Abbott Laboratories announced plans to spin off its nutrition business, which includes baby formula, into an independent, publicly traded company by the end of 2027. Alongside the planned separation of the $8.5 billion nutrition arm, the company lowered its full-year 2026 sales growth outlook to 6 percent from a previous range of 6.5 percent to 7.5 percent. Following the earnings release and structural shakeup, Abbott stock fell as investors reacted to the lower projections and ongoing challenges within the unit.Why it mattersThe strategic overhaul follows a $385 million settlement tied to a p